Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Anticancer Research|December 1, 2022
Risk of Abemaciclib-induced Liver Injury in Hormone Receptor-positive, HER2-negative Metastatic Breast Cancer: A Retrospective AnalysisAzusa Taniguchi, Nobuyoshi Kittaka, Haruka Kanaoka, et al.
Scientific Reports|November 27, 2023
Early detection of brain metastases and appropriate local therapy followed by systemic chemotherapy may improve the prognosis of gastric cancerYasunobu Ishizuka, Takeshi Omori, Naoki Shinno, et al.
Therapeutic Drug Monitoring|November 17, 2016
A Simple High-Performance Liquid Chromatography for Determining Lapatinib and Erlotinib in Human PlasmaMasahiro Ohgami, Masato Homma, Yoshiharu Suzuki, et al.
Surgical Case Reports|August 12, 2022
Pegfilgrastim-induced vasculitis of the subclavian and basilar artery complicated by subarachnoid hemorrhage in a breast cancer patient: a case report and review of the literatureYukiko Seto, Nobuyoshi Kittaka, Azusa Taniguchi, et al.
BMC Cancer|August 12, 2024
Clinical significance of germline breast cancer susceptibility gene (gBRCA) testing and olaparib as maintenance therapy for patients with pancreatic cancerYasuharu Kawamoto, Takuo Yamai, Kenji Ikezawa, et al.
Breast Cancer (Tokyo, Japan)|October 2, 2023
Predictive factors for response to neoadjuvant chemotherapy: inflammatory and immune markers in triple-negative breast cancerHiroki Kusama, Nobuyoshi Kittaka, Ai Soma, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 17, 2025
[Current Status and Issue of Emesis and Vomiting Caused by Trastuzumab Deruxtecan]Ai Soma, Fumie Fujisawa, Ayako Higuchi, et al.
Breast Cancer (Tokyo, Japan)|July 6, 2026
Abemaciclib plus endocrine therapy in chemotherapy-treated patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancerKazutaka Narui, Kana Miyahara, Yukari Uemura, et al.
Breast Cancer (Tokyo, Japan)|January 3, 2021
STK11 loss drives rapid progression in a breast cancer patient resulting in pulmonary tumor thrombotic microangiopathyFumie Fujisawa, Kei Kunimasa, Rieko Kano-Fujiwara, et al.
Acta Haematologica|April 15, 2015
Measurement of Proteasome Activity in Peripheral Blood Mononuclear Cells as an Indicator of Susceptibility to Bortezomib-Induced Severe Neurological Adverse Events in Patients with Multiple MyelomaYukiko Cho, Mitsuo Hori, Yasushi Okoshi, et al.
Pageof 4